More stories
Q1’25 Psychedelic Drug Development Pipeline: Bullseye Chart
Q1’25 BULLSEYE CHART We map our Q1’25 Psychedelics Drug Development Tracker data onto a ‘bullseye chart’ format. Given the number of candidates included, we...
How Do You Find the Right Facilitator? The Art of Matchmaking in Psychedelic Healing
More and more people are looking to have psychedelic experiences every day, but what do you do if you don’t know who to go...
Pα+ Psychedelic Bulletin #186: As Trump Takes Office, Impact on Psychedelics Field Remains Unclear;...
Google co-founder Sergey Brin was given a prominent spot on the seating arrangement for Trump’s inauguration on Monday. He was sat among fellow billionaires...
Bifurcation Squared: Compass Lobbies for Narrow Rescheduling in Colorado, Virginia; Pushes Back on State...
Here, we take a look at Compass Pathways’ lobbying agenda, with a particular focus on a Colorado bill that the company is backing, as...
Is the DEA Sabotaging Psychedelic Research? Inside the Push to Schedule DOI and DOC
In this episode, Joe interviews renowned chemist, filmmaker, and journalist, Hamilton Morris. After originally backing down from its first attempt in 2022, the DEA...
Psychedelics in 2024: From Hype to Hard Realities
In a video address to supporters reflecting on 2024, MAPS founder Rick Dobin proclaimed: “This year has tested us like never before.”While Johns Hopkins...
mpathic Co-Founder Danielle Schlosser on AI Oversight of Psychedelics Trials
In our latest Pα+ interview, Psychedelic Alpha Editor Josh Hardman sits down with Danielle Schlosser, co-founder and Chief Innovation Officer at mpathic, an AI-powered...
Patent Analysis: Lykos Suffers Blow from USPTO As All Patent Claims Stand Finally Rejected
The future direction of MDMA drug developer Lykos Therapeutics is uncertain on many fronts since the FDA rejected its new drug application last Summer....
Kama Flight: The Healing Power of Somatic Movement, Communication, and Trust
As society becomes more virtual and disconnected, many of us are looking for new ways to touch, feel, and connect. What is Kama Flight,...
PsychedeliCare Launches First European Citizens’ Initiative Demanding Political Action on Psychedelic-Assisted Therapies
Words by Charles Bliss for Psychedelic Alpha. From 14 January 2025, the PsychedeliCare European Citizens’ Initiative (ECI) has 12 months to gather one million...
Pα+ Psychedelic Bulletin #185: Joe Rogan on Ibogaine; Wisconsin Medicaid to Cover IV Ketamine...
Last Friday, former Texas Governor Rick Perry and ibogaine evangelist Bryan Hubbard appeared on The Joe Rogan Experience podcast for a two-hour interview with...
Billionaire Investor Antonio Gracias Plots $100M Lykos Takeover with Doblin’s Backing
Billionaire investor Antonio Gracias has launched a bid to take control of MDMA drug developer Lykos Therapeutics via $100M of funding and a closer...
